Rs1113129
From SNPedia
| Orientation | plus |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1113129 |
| PheGenI | rs1113129 |
| nextbio | rs1113129 |
| hapmap | rs1113129 |
| 1000 genomes | rs1113129 |
| hgdp | rs1113129 |
| ensembl | rs1113129 |
| gopubmed | rs1113129 |
| geneview | rs1113129 |
| scholar | rs1113129 |
| rs1113129 | |
| pharmgkb | rs1113129 |
| gwascentral | rs1113129 |
| openSNP | rs1113129 |
| 23andMe | rs1113129 |
| 23andMe all | rs1113129 |
| SNP Nexus | |
| SNPshot | rs1113129 |
| SNPdbe | rs1113129 |
| MSV3d | rs1113129 |
| Gene | CYP2C8 |
| Chromosome | 10 |
| Orientation | plus |
| GMAF | 0.3292 |
| Position | 96811045 |
| Reference | GRCh37 37.1/132 |
| Max Magnitude |
| Make rs1113129(C;C) |
| Make rs1113129(C;G) |
| Make rs1113129(G;G) |
| ? | (C;C) (C;G) (G;G) | 28 |
|---|---|---|
[PMID 18303964] Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids.
[PMID 18769365] Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.
[PMID 19761371] Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies.
| GET Evidence | |
|---|---|
| rs1113129 | |
| aa_change | |
| aa_change_short | |
| impact | pharmacogenetic |
| qualified_impact | Insufficiently evaluated pharmacogenetic |
| overall_frequency | 0.33871 |
| summary | |
